Open AccessDevelopment and Validation of Q-Absorbance Ratio by UV-Spectrophotometric Method for Simultaneous Estimation of Metformin and Empagliflozin in Bulk and Combined Dosage Form
Author(s) -
Pushpendra Kumar Sharma,
Srinivasarao Kosanam,
Surendra Singh Rao
Publication year - 2021
Publication title -
journal of drug delivery and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2250-1177
DOI - 10.22270/jddt.v11i2-s.4624
Subject(s) - glimepiride , empagliflozin , pioglitazone , metformin , chromatography , dosage form , sitagliptin , chemistry , degradation (telecommunications) , simvastatin , absorbance , pharmacology , medicine , type 2 diabetes , computer science , diabetes mellitus , insulin , telecommunications , endocrinology
Advantages of simultaneous stability studies are the identification of new degradation products, to understand mutual induction and/or inhibition of rates of degradation and to analyze the degradation products of both drugs. Various ultraviolet spectroscopic and high performance liquid chromatographic assay methods were reported for the estimation of metformin, sitagliptin, pioglitazone, glimepiride and simvastatin individually and in combination with other drugs. All the above reported methods were based on the estimation of metformin, sitagliptin, pioglitazone, glimepiride and simvastatin alone or in combination with other drugs. The degradation products were generated and successfully separated by the developed and validated high performance liquid chromatographic methods for the estimation of the selected anti-diabetic drug combinations. The aim of the study was to develop and validate of Q-Absorbance Ratio UV-Spectrophotometric Method for Simultaneous Estimation of Metformin and Empagliflozin in Bulk and Combined Dosage Form.
Keywords: Metformin, Method Development, Validation, Empagliflozin, UV-Spectrophotometer.